The global hospital bed market continues to grow at a relaxed pace, but growth at LINET Group has been fast. In the fiscal year ending in March of 2018, the company earned 252 million euros, which is 11.5% more than the year before, and EBITDA climbed to just under 40 million euros. Growth has been confirmed by this year’s results – in November, LINET is supplying customers with a total of 14,000 beds.
‘Profits were negatively impacted by both the strengthening of the Czech koruna and the weakening of the dollar against the euro. Despite this, we’ve succeeded in sticking to our ambitious plans for growth. We’re outgrowing the market to the detriment of our competitors,’ says LINET Group managing director Tomáš Kolář.
Through organic growth, the company is aiming by 2020 to achieve sales of 400 million euros, which at an exchange rate of 26 CZK/EUR equates to 10.5 billion CZK. Sales growth and targets for actual fiscal year are shown in the following table:
From 1 April to 30 September 2018, LINET Group’s sales exceeded 120 million euros, which is 10.6% more than for the same period last year, and EBITDA jumped by 25% to 15.5 million euros.
‘We always pick up speed in the second half of the fiscal year. In fact, this November is going to be our absolute strongest month in the history of the company, as we’re shipping out 14,000 beds across the group. In Želevčice, we’re manufacturing 7,900 beds and sending 9,000 beds to customers. That’s also a record for us,’ adds Tomáš Kolář.